首页> 外文OA文献 >The Selective Anaplastic Lymphoma Receptor Tyrosine Kinase Inhibitor ASP3026 Induces Tumor Regression and Prolongs Survival in Non–Small Cell Lung Cancer Model Mice

【2h】

The Selective Anaplastic Lymphoma Receptor Tyrosine Kinase Inhibitor ASP3026 Induces Tumor Regression and Prolongs Survival in Non–Small Cell Lung Cancer Model Mice

机译：选择性内塑性淋巴瘤受体酪氨酸激酶抑制剂ASP3026诱导肿瘤回归，延长非小细胞肺癌模型小鼠的存活

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Masamichi Mori; Yoko Ueno; Satoshi Konagai; Hiroshi Fushiki; Itsuro Shimada; Yutaka Kondoh; Rika Saito; Kenichi Mori; Nobuaki Shindou; Takatoshi Soga; Hideki Sakagami; Takashi Furutani; Hitoshi Doihara; Masafumi Kudoh; Sadao Kuromitsu;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The Selective Anaplastic Lymphoma Receptor Tyrosine Kinase Inhibitor ASP3026 Induces Tumor Regression and Prolongs Survival in Non-Small Cell Lung Cancer Model Mice [J] . Mori Masamichi, Ueno Yoko, Konagai Satoshi, Molecular cancer therapeutics . 2014,第2期

机译：选择性间变性淋巴瘤受体酪氨酸激酶抑制剂ASP3026诱导肿瘤消退并延长非小细胞肺癌模型小鼠的存活率。
2. Real-World Treatment Patterns and Progression-Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non-Small Cell Lung Cancer [J] . Mohammad Jahanzeb, Huamao M. Lin, Xiaoyun Pan, The oncologist . 2020,第10期

机译：与Anploplastic淋巴瘤激酶（ALK）酪氨酸激酶抑制剂疗法的真实世界治疗模式和无进展生存期用于ALK +非小细胞肺癌
3. Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non-Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I Trial. [J] . Herbst RS, Maddox AM, Rothenberg ML, Journal of Clinical Oncology . 2002,第18期

机译：选择性口服表皮生长因子受体酪氨酸激酶抑制剂ZD1839通常耐受性良好，并且在非小细胞肺癌和其他实体瘤中具有活性：I期试验的结果。
4. Selective tyrosine kinase inhibitor, STI571, inhibitsgrowth of p53 mutant anaplastic thyroid cancer cellsby inducing S-G2 transition arrest [C] . Alexei P. Podtcheko, Satoshi Tsuda, Akira Ohtsuru International Consortium for Medical Care of Hibakusha and Radiation Life Science . 2003

机译：选择性酪氨酸激酶抑制剂，STI571，P53突变体的抑制性诱导S-G2过渡逮捕的抑制性甲状腺癌细胞
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+Non‐Small Cell Lung Cancer [O] . Mohammad Jahanzeb, Huamao M. Lin, Xiaoyun Pan, 2020

机译：与Anaploprastic淋巴瘤激酶（ALK）酪氨酸激酶抑制剂疗法的真实世界治疗模式和无进展生存非小细胞肺癌
7. Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase ( ALK ) Tyrosine Kinase Inhibitor Therapies for ALK + Non‐Small Cell Lung Cancer [O] . Mohammad Jahanzeb, Huamao M. Lin, Xiaoyun Pan, 2020

机译：与Anploplastic淋巴瘤激酶（ALK）酪氨酸激酶抑制剂疗法相关的真实世界治疗模式和无进展生存期适用于ALK +非小细胞肺癌的疗法

The Selective Anaplastic Lymphoma Receptor Tyrosine Kinase Inhibitor ASP3026 Induces Tumor Regression and Prolongs Survival in Non–Small Cell Lung Cancer Model Mice

著录项

引文网络

相似文献

相关主题

期刊订阅